Serum Lp(α), insulin resistance, metabolic risk factors for cardiovascular disease, and the long term effects of bezafibrate in type 2 diabetes
Keyword(s):
2005 ◽
Vol 1
(3)
◽
pp. 231-243
◽
Keyword(s):
2008 ◽
Vol 80
(3)
◽
pp. 399-404
◽
Keyword(s):
Keyword(s):
2002 ◽
Vol 76
(2)
◽
pp. 390-398
◽
Keyword(s):
2019 ◽
Vol 87
(March)
◽
pp. 851-851
2018 ◽
Vol 20
(6)
◽
pp. 1419-1426
◽
Keyword(s):
Keyword(s):
2009 ◽
Vol 84
(1)
◽
pp. 92-98
◽
Keyword(s):
Keyword(s):